<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05065580</url>
  </required_header>
  <id_info>
    <org_study_id>EGME#05-2021</org_study_id>
    <nct_id>NCT05065580</nct_id>
  </id_info>
  <brief_title>OMT as an Adjunctive Treatment in MDD</brief_title>
  <official_title>Osteopathic Manipulative Treatment as an Adjunctive Treatment in Major Depressive Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Spectrum Health - Lakeland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Spectrum Health - Lakeland</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      participants will be receiving OMT 1x/week for 8 weeks. Each appointment with be a duration&#xD;
      of 30 minutes. Patients will be required to fill out PHQ-9 and SSS-8 questionnaires before&#xD;
      beginning the study and following the conclusion of the study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 12, 2021</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PHQ-9 results post treatment</measure>
    <time_frame>8 weeks</time_frame>
    <description>compare PHQ-9 results in the two groups based on SSS-8 score before and after treatment</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>Pre test</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Post test</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pre-test</intervention_name>
    <description>no OMT treatment</description>
    <arm_group_label>Pre test</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>post-test</intervention_name>
    <description>OMT Treatment for 8 weeks</description>
    <arm_group_label>Post test</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients 18-65, patients with diagnosis of MDD, PHQ-9 score &gt; 10 at screening and&#xD;
             baseline&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of mania, hypomania, or psychosis as defined in DSM V&#xD;
&#xD;
          -  current substance abuse, including abuse within the previous 6 months&#xD;
&#xD;
          -  patients with a cognitive disorder or dementia&#xD;
&#xD;
          -  patients with other axis I diagnosis (anxiety disorders, dissociative disorders, etc.)&#xD;
             that was primary in the past 6 months&#xD;
&#xD;
          -  receiving other forms of manual therapy during study&#xD;
&#xD;
          -  authors belief that there was significant suicidal risk&#xD;
&#xD;
          -  changes in medication or psychotherapy within 6 weeks of starting study or during&#xD;
             study period&#xD;
&#xD;
          -  history of migraines&#xD;
&#xD;
          -  presence of any other significant organic disease (infectious, cardiac, pulmonary,&#xD;
             gastrointestinal, renal, etc.)&#xD;
&#xD;
          -  other absolute contraindications to OMT (malignancy, infection, myelopathy, severe&#xD;
             osteoporosis, increased ICP, intracranial bleeding, fractures, etc.)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Lakeland Regional Healthcare</name>
      <address>
        <city>Saint Joseph</city>
        <state>Michigan</state>
        <zip>49085</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelino Mancini, DO, FAOECP</last_name>
      <phone>269-983-4081</phone>
      <email>mmancini@lakelandhealth.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 23, 2021</study_first_submitted>
  <study_first_submitted_qc>October 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 4, 2021</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

